Dr. Pashtoon Kasi, MS
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Studies Colorectal Cancer
Studies Colon Cancer
19 reported clinical trials
48 drugs studied
About Pashtoon Kasi, MS
Education:
- Earned an MD from Aga Khan University (AKU) in Pakistan, 2006.
- Completed an MS at Mayo Graduate School of Graduate Medical Education (MSGME), Mayo Clinic, 2018.
Experience:
- Completed a Fellowship in Oncology and Hematology at Mayo Clinic in 2016.
- Served as Associate and Assistant Professor of Medicine and Oncology at the University of Iowa and Mayo Clinic.
- Currently an oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, with a focus on gastrointestinal cancers.
- Holds the position of Director for Colorectal Cancer Research and Precision Medicine Director for Liquid Biopsy Research at the Englander Institute of Precision Medicine.
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
Stage I
2Colon Cancer
Stage IV
Stage III
BRAF negative
Affiliated Hospitals
Clinical Trials Pashtoon Kasi, MS is currently running
Immunotherapy + Chemotherapy
for Rectal Cancer
This trial uses a combination of radiation therapy, medication, and chemotherapy to treat patients with advanced pelvic tumors. The goal is to shrink the tumors, kill cancer cells, and enhance the overall effectiveness of the treatment.
Recruiting1 award Phase 22 criteria
Ramucirumab + Trifluridine/Tipiracil or Paclitaxel
for Gastric Cancer
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria
More about Pashtoon Kasi, MS
Clinical Trial Related3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Pashtoon Kasi, MS has experience with
- Irinotecan
- Oxaliplatin
- Paclitaxel
- Trastuzumab
- Tucatinib
- Ramucirumab
Breakdown of trials Pashtoon Kasi, MS has run
Colorectal Cancer
Colon Cancer
Stomach Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pashtoon Kasi, MS specialize in?
Pashtoon Kasi, MS focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Pashtoon Kasi, MS currently recruiting for clinical trials?
Yes, Pashtoon Kasi, MS is currently recruiting for 6 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Pashtoon Kasi, MS has studied deeply?
Yes, Pashtoon Kasi, MS has studied treatments such as Irinotecan, Oxaliplatin, Paclitaxel.
What is the best way to schedule an appointment with Pashtoon Kasi, MS?
Apply for one of the trials that Pashtoon Kasi, MS is conducting.
What is the office address of Pashtoon Kasi, MS?
The office of Pashtoon Kasi, MS is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.